ARCHIVES

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Vince DeVita: Startup Funds For New Clinical Research Difficult To Get; Many Private Physicians More Capable Of Caring For Cancer Patients Than Those In Centers

July 16, 1976

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Mammography Summit Planned For June In Milan.

March 1, 2002

Public Meeting On Ionizing Radiation Set

January 11, 1980

Public Health Service: Blumenthal Declines White House Job

November 14, 1997

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

January 28, 2011